Brawn Biotech Ltd Share Price Today - Brawn Biotech Ltd Stock Price Live NSE/BSE

Brawn Biotech Ltd

NSE: BSE: 530207

₹20.10

(4.96%)

Mon, 30 Mar 2026, 02:40 am

MTF 5xInvest in Brawn Biotech Ltd with 5x Leverage Buy with MTF

Market Cap60.31M

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Brawn Biotech Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
5.70
Net Profit
-1.74
P/B
1.45
Sector P/E
31.93
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
-41.33
ROCE
-18.71
Debt/Equity
0
EPS (TTM)
0.62
Dividend Yield
0
Book Value
10
Interest Cover
0

Analysis

all

Pros

Brawn Biotech is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Brawn Biotech is profitable, therefore cash runway is not a concern.
Brawn Biotech is profitable, therefore cash runway is not a concern.
Brawn Biotech has no debt, it does not need to be covered by operating cash flow.
Brawn Biotech has no debt, it does not need to be covered by short term assets.

Cons

Unable to calculate sustainability of dividends as Brawn Biotech has not reported any payouts.
Unable to evaluate Brawn Biotech's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Brawn Biotech's dividend against the top 25% market benchmark as the company has not reported any payouts.
The average tenure for the Brawn Biotech board of directors is less than 3 years, this suggests a new board.
The average tenure for the Brawn Biotech management team is less than 2 years, this suggests a new team.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	53.39	53.66	53.66	53.66	53.64
FII	0	0	0	0	0
DII	0.35	0.35	0.35	0.35	0.35
Public	46.26	45.99	45.99	45.99	46.01
Government	0	0	0	0	0

Technical Analysis

RSI

53.84

MACD

-0.04

50 DMA

20.51

200 DMA

19.74

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	30.63	25.74	24.00	20.85	19.11	15.96	11.07
Fibonacci	25.74	23.88	22.72	20.85	18.99	17.83	15.96
Camarilla	23.59	23.15	22.70	20.85	21.80	21.35	20.91

Pivots Level: Classic

+9.78

30.63

+4.89

25.74

+3.14

24.00

20.85

Pivot Point

LTP: 20.85

-1.75

19.11

-4.89

15.96

-9.78

11.07

Moving Average

SMAEMA

Period

Value

10-EMA
20.12
20-EMA
20.12
30-EMA
20.18
50-EMA
20.33
100-EMA
20.40
200-EMA
20.20

Announcement Date	Purpose	Action	Ex Date
14 Nov 2025	board-meetings	Quarterly Results
04 Sept 2025	agm
29 Aug 2024	agm
23 Aug 2023	agm
01 Sept 2022	agm
12 Aug 2021	agm
29 May 2018	dividend	₹1.00 Dividend /Share	15 Sept 2018
30 May 2017	dividend	₹1.50 Dividend /Share	16 Sept 2017

Brawn Biotech Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd

Lupin Ltd

Sun Pharmaceutical Industries Ltd

Brawn Biotech Ltd About

Brawn Biotech Pharmaceutical Products cover all major product segments like Antibacterial, Cardiovascular, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarial, and Nutritionals. BRAWN

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1985

Headquarters

CEO

B R Gupta

Employees

Contact

Website

http://www.brawnbiotech.com

solution@brawnbiotech.com

Phone

Location

C-64 Lajpat Nagar-1 1st Floor, , New Delhi, New Delhi, 110024

Year	History
1989	The company started registering an average growth of 53% in its turnover.
1993	The company was converted into a public limited company.
2002	Shri Satinder Kumar Saini resigned as Director of the Company.
2007	The company appointed Shri. Manohar Lal, Shri. Mahesh Kumar Nanchal and Shri. Trilok Chand Sharma as Additional Directors.
2011	The company changed its name from Brawn Pharmaceuticals Ltd. to Brawn Biotech Ltd.

Client Name	Order Side	QTY	Avg Price	Date
NAIMABBAS ANVARALI JAMANI	Buy	17650	22.76	20 Dec 2024
NAIMABBAS ANVARALI JAMANI	Sell	2000	22.5	20 Dec 2024
GUNMALA JAIN	Sell	18102	59	06 Jan 2016
KALPANAAGRAWAL	Sell	21850	19.77	09 Jun 2009
R K TULI	Sell	15200	34.68	29 May 2009

Brawn Biotech Ltd News

Brawn Biotech Appoints New Auditors for FY 2025-26

Brawn Biotech Limited's board approved the appointment of Mr. Viney as Secretarial Auditor and M/s Sahil Pasricha & Associates as Internal Auditors for financial year 2025-26, effective March 25, 2026.

25 Mar 2026

companies

Brawn Biotech Reports Q3 FY26 Financial Results

Brawn Biotech Limited announced Q3 FY26 quarterly results for quarter ended 31st December 2025, showing revenue from operations of ₹5.10 lakhs with comprehensive income of ₹5.00 lakhs.

14 Feb 2026

co actions results

Brawn Biotech Appoints Rati Garg as New CFO

Brawn Biotech Limited's board appointed Ms. Rati Garg as Chief Financial Officer and Key Managerial Personnel effective February 1, 2026, following board meeting on January 30, 2026.

30 Jan 2026

stocks

Brawn Biotech Director Brij Bala Gupta Resigns

Brawn Biotech Limited announces resignation of Director Mrs. Brij Bala Gupta effective November 25, 2025, citing pre-occupation and unavoidable circumstances as reasons for departure.

22 Dec 2025

stocks

Brawn Biotech Director Mrs. Brij Bala Gupta Resigns Due to Pre-occupation and Unavoidable Circumstances

Mrs. Brij Bala Gupta resigned from the Board of Directors of Brawn Biotech Limited effective November 25, 2025, citing pre-occupation and certain unavoidable circumstances. The company confirmed there are no other material reasons for the resignation and will present the resignation letter with detailed reasons at the next Board meeting.

25 Nov 2025

corporate governance

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800